Michael Ryan - Jul 12, 2021 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBP)

Role
CHIEF BIOINFORMATICS RESEARCH OFFICER
Signature
/s/ Michael Ryan
Stock symbol
KRBP
Transactions as of
Jul 12, 2021
Transactions value $
$0
Form type
4
Date filed
8/2/2021, 03:05 PM
Previous filing
Jul 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRBP Common Stock Other $0 +50.2K $0.00 50.2K Jul 13, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRBP Restricted Stock Units Other $0 +32K $0.00 32K Jul 12, 2021 Common Stock 32K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securites were acquired pursuant to a Membership Interest Purchase Agreement dated as of June 14, 2021 among Kiromic Biopharma, Inc., InSilico Solutions, LLC and Michael Ryan.
F2 Each restricted stock unit is the economic equivalent of one share of Kiromic Biopharma, Inc. common stock.
F3 The vesting schedule is such that 25% of the RSUs vest on June 30, 2022, and the remainder will vest at a rate of 1/36th per month for 36 months thereafter.

Remarks:

CHIEF BIOINFORMATICS RESEARCH OFFICER